Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Buy Rubicon Research; target of Rs 955: Motilal Oswal
Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 955 in its research report dated April 15, 2026.
Buy Five Star Business Finance; target of Rs 600: Motilal Oswal
Motilal Oswal recommended is bullish on Five Star Business Finance recommended buy rating on the stock with a target price of Rs 600 in its research report dated Jun 22, 2026.
Closing Bell: Nifty above 23,100, Sensex gain 509 pts; IT, metal, realty shine
Biggest Nifty gainers were Wipro, Hindalco Industries, HCL Technologies, TCS, Infosys, while losers included Dr Reddy's Laboratories, Adani Enterprises, Interglobe Aviatoion, Apollo Hospitals, Adani Ports. Except Consumer Durables and PSU Bank, all other sectoral indices ended in the green with Information Technology rose 2.5%, Metal index gained 1.5%, Realty index up 1.7% and Media index jumped 1%. The Nifty midcap index was up 0.3 percent, while smallcap index ended flat.
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated March 19, 2026.
Buy Star Health; target of Rs 700: Motilal Oswal
Motilal Oswal is bullish on Star Health recommended buy rating on the stock with a target price of Rs 700 in its research report dated Jun 25, 2026.
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated February 25, 2026.
Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal
Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5525 in its research report dated February 14, 2026.
Neutral Eris Lifesciences; target of Rs 1520: Motilal Oswal
Motilal Oswal recommended Neutral rating on Eris Lifesciences with a target price of Rs 1520 in its research report dated February 14, 2026.
Neutral Lupin; target of Rs 2360: Motilal Oswal
Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2360 in its research report dated February 14, 2026.
Neutral Torrent Pharma; target of Rs 4300: Motilal Oswal
Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 4300 in its research report dated February 14, 2026.